- Home
- VCEL vs BBU Comparison
VCEL vs BBU Comparison
Compare VCEL & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- BBU
- Stock Information
- Founded
- VCEL 1989
- BBU 2016
- Country
- VCEL United States
- BBU Bermuda
- Employees
- VCEL N/A
- BBU N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- BBU Engineering & Construction
- Sector
- VCEL Health Care
- BBU Consumer Discretionary
- Exchange
- VCEL Nasdaq
- BBU Nasdaq
- Market Cap
- VCEL 2.1B
- BBU 2.2B
- IPO Year
- VCEL 1997
- BBU N/A
- Fundamental
- Price
- VCEL $43.82
- BBU $24.91
- Analyst Decision
- VCEL Strong Buy
- BBU Buy
- Analyst Count
- VCEL 8
- BBU 5
- Target Price
- VCEL $62.00
- BBU $31.00
- AVG Volume (30 Days)
- VCEL 492.2K
- BBU 24.1K
- Earning Date
- VCEL 07-31-2025
- BBU 08-01-2025
- Dividend Yield
- VCEL N/A
- BBU 1.00%
- EPS Growth
- VCEL 521.85
- BBU N/A
- EPS
- VCEL 0.05
- BBU N/A
- Revenue
- VCEL $238,541,000.00
- BBU $35,354,000,000.00
- Revenue This Year
- VCEL $23.03
- BBU N/A
- Revenue Next Year
- VCEL $24.52
- BBU N/A
- P/E Ratio
- VCEL $837.82
- BBU N/A
- Revenue Growth
- VCEL 14.80
- BBU N/A
- 52 Week Low
- VCEL $37.39
- BBU $16.85
- 52 Week High
- VCEL $63.00
- BBU $26.75
- Technical
- Relative Strength Index (RSI)
- VCEL 58.48
- BBU 57.79
- Support Level
- VCEL $39.16
- BBU $25.04
- Resistance Level
- VCEL $44.50
- BBU $25.73
- Average True Range (ATR)
- VCEL 1.59
- BBU 0.66
- MACD
- VCEL 0.28
- BBU -0.08
- Stochastic Oscillator
- VCEL 87.27
- BBU 41.84
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About BBU Brookfield Business Partners L.P. Limited Partnership Units
Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.